MED Prekyba - Company finances
|
EUR
|
2020
From: 2020-10-14
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 5,764 | 16,382 | 10,749 | 10,689 | 29,141 | 94,868 |
| Profit before tax | -5 | 4,316 | 3,619 | 464 | 2,618 | 7,626 |
| Net profit | -5 | 4,100 | 3,438 | 441 | 2,487 | 7,168 |
| Equity | 1,995 | 6,096 | 9,533 | 9,974 | 12,460 | 19,629 |
| Liabilities | - | - | 955 | 116 | 1,293 | 13,329 |
| Non-current assets | 0 | 345 | 192 | 39 | 0 | 0 |
| Current assets | 2,208 | 6,503 | 10,296 | 10,051 | 13,753 | 32,958 |
| Total assets | 2,208 | 6,848 | 10,488 | 10,090 | 13,753 | 32,958 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 717 | 1,950 | 2,601 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +184.2% | -34.4% | -0.6% | +172.6% | +225.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.2% | 59.9% | 32.8% | 4.4% | 18.1% | 21.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -0.3% | 67.3% | 36.1% | 4.4% | 20.0% | 36.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.1% | 25.0% | 32.0% | 4.1% | 8.5% | 7.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -0.1% | 26.3% | 33.7% | 4.3% | 9.0% | 8.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.1 | 0.0 | 0.1 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MED Prekyba - Social security debts
The company had no debts to Sodra
MED Prekyba - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MED Prekyba, MB (code 305641447) is a Lithuanian small partnership engaged in the retail sale of other medical and orthopaedic goods. In 2025, the latest financial year, the company generated revenue of €94.9K and net profit of €7.2K, with a profit margin of 7.6%. Performance strengthened sharply from 2024, when revenue was €29.1K and net profit €2.5K, and from 2023, when revenue was €10.7K and net profit €441. Over the two-year period, revenue increased substantially, reflecting rapid business expansion. The balance sheet also grew, with total assets rising to €33.0K in 2025 from €13.8K in 2024 and €10.1K in 2023. Equity reached €19.6K, while liabilities stood at €13.3K, giving an equity ratio of 59.6% and debt-to-equity of 0.68. Return on equity was 36.5%, return on assets 21.8%, and asset turnover 2.88x, indicating efficient use of the asset base.